Assessing mumps outbreak risk in highly vaccinated populations using spatial seroprevalence data
Mumps is a potentially severe viral infection. The incidence of mumps has declined dramatically in high-income countries since the introduction of mumps antigen-containing vaccines. However, recent large outbreaks of mumps in highly vaccinated populations suggest waning of vaccine-induced immunity and primary vaccine failure. In this paper we present a simple method for identifying geographic regions with high outbreak potential, demonstrated using 2006 mumps seroprevalence data from Belgium and Belgian vaccination coverage data. Predictions of the outbreak potential in terms of the effective reproduction number in future years signal an increased risk of new mumps outbreaks. Literature reviews on serological information for both primary vaccine failure and waning immunity provide essential information for our predictions. Tailor-made additional vaccination campaigns would be valuable for decreasing local pockets of susceptibility, thereby reducing the risk of future large-scale mumps outbreaks.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2014 |
|---|---|
| Erschienen: |
2014 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:179 |
|---|---|
| Enthalten in: |
American journal of epidemiology - 179(2014), 8 vom: 15. Apr., Seite 1006-17 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Abrams, Steven [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 12.05.2014 Date Revised 20.08.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1093/aje/kwu014 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM235887072 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM235887072 | ||
| 003 | DE-627 | ||
| 005 | 20231224104349.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2014 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/aje/kwu014 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0786.xml |
| 035 | |a (DE-627)NLM235887072 | ||
| 035 | |a (NLM)24573540 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Abrams, Steven |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Assessing mumps outbreak risk in highly vaccinated populations using spatial seroprevalence data |
| 264 | 1 | |c 2014 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 12.05.2014 | ||
| 500 | |a Date Revised 20.08.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Mumps is a potentially severe viral infection. The incidence of mumps has declined dramatically in high-income countries since the introduction of mumps antigen-containing vaccines. However, recent large outbreaks of mumps in highly vaccinated populations suggest waning of vaccine-induced immunity and primary vaccine failure. In this paper we present a simple method for identifying geographic regions with high outbreak potential, demonstrated using 2006 mumps seroprevalence data from Belgium and Belgian vaccination coverage data. Predictions of the outbreak potential in terms of the effective reproduction number in future years signal an increased risk of new mumps outbreaks. Literature reviews on serological information for both primary vaccine failure and waning immunity provide essential information for our predictions. Tailor-made additional vaccination campaigns would be valuable for decreasing local pockets of susceptibility, thereby reducing the risk of future large-scale mumps outbreaks | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a disease outbreaks | |
| 650 | 4 | |a effective reproduction number | |
| 650 | 4 | |a mumps | |
| 650 | 4 | |a next-generation operator | |
| 650 | 4 | |a serology | |
| 650 | 4 | |a social contact hypothesis | |
| 650 | 4 | |a vaccination coverage | |
| 650 | 4 | |a vaccines | |
| 650 | 7 | |a Antibodies, Viral |2 NLM | |
| 650 | 7 | |a Immunoglobulin G |2 NLM | |
| 650 | 7 | |a Measles-Mumps-Rubella Vaccine |2 NLM | |
| 700 | 1 | |a Beutels, Philippe |e verfasserin |4 aut | |
| 700 | 1 | |a Hens, Niel |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t American journal of epidemiology |d 1965 |g 179(2014), 8 vom: 15. Apr., Seite 1006-17 |w (DE-627)NLM000012327 |x 1476-6256 |7 nnns |
| 773 | 1 | 8 | |g volume:179 |g year:2014 |g number:8 |g day:15 |g month:04 |g pages:1006-17 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/aje/kwu014 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 179 |j 2014 |e 8 |b 15 |c 04 |h 1006-17 | ||